EMEA-001742-PIP02-16
Key facts
Active substance |
Derivative of 4H-pyrazolo[3,4-d]pyrimidin-4-one
|
Therapeutic area |
Psychiatry
|
Decision number |
P/0338/2016
|
PIP number |
EMEA-001742-PIP02-16
|
Pharmaceutical form(s) |
Film-coated tablet
|
Condition(s) / indication(s) |
Prevention of psychosis
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Boehringer Ingelheim International GmbH
Tel. +49 6132 778271 |
Decision type |
RP: decision refers to a refusal on a proposed Paediatric Investigation Plan
|